Cyblex D 30 XR Tablet

Introduction

Cyblex D is a prescription medication that combines two active ingredients: Dapagliflozin and Gliclazide. Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and Gliclazide is a sulfonylurea. This medication is primarily used to manage type 2 diabetes mellitus.

Uses

Cyblex D is prescribed to lower blood sugar levels in adults with type 2 diabetes mellitus. It is used as an adjunct to diet and exercise to help control blood glucose levels. This medication can be used alone or in combination with other antidiabetic medications when diet and exercise alone are not sufficient.

Dosage and Administration

The dosage of Cyblex D may vary depending on individual patient needs. Follow the instructions provided by your healthcare provider. Generally, the recommended starting dose is one tablet taken orally once daily. The tablet should be taken with or without food. Your healthcare provider may adjust the dosage based on your response to treatment and your blood sugar levels.

Mechanism of Action

Dapagliflozin, one of the active ingredients in Cyblex D, works by inhibiting SGLT2 in the kidneys. This reduces the reabsorption of glucose and increases the excretion of glucose in the urine, thereby lowering blood sugar levels. Gliclazide, on the other hand, stimulates the release of insulin from the pancreas, helping to further control blood sugar levels.

Side Effects

Common side effects may include urinary tract infections, increased urination, genital yeast infection, and hypoglycemia (low blood sugar levels). Serious side effects are rare but can include ketoacidosis (a serious condition that may require hospitalization) and hypersensitivity reactions. If you experience any severe or persistent side effects, seek medical attention immediately.

Drug Interactions

inform your healthcare provider about all the medications you are taking, including prescription, over-the-counter, and herbal products. Cyblex D may interact with certain medications, such as diuretics, insulin, and certain drugs that affect the liver or kidney function. These interactions can affect the effectiveness or safety of the medication. Your healthcare provider will consider these interactions when prescribing Cyblex D and may adjust the dosage or recommend alternative treatments if necessary.

Precautions

Before taking Cyblex D, discuss your medical history and any pre-existing conditions with your healthcare provider. This medication may not be suitable for everyone, particularly those with severe kidney problems, type 1 diabetes, or a history of hypersensitivity to sulfonylureas. Avoid excessive alcohol consumption while taking this medication, as it can increase the risk of hypoglycemia. Additionally, Cyblex D may cause dizziness or drowsiness, so caution should be exercised when operating machinery or driving.

Storage

Patient Tips

• Take Cyblex D exactly as prescribed by your healthcare provider.
• Follow a healthy diet and exercise regularly while taking this medication to help control blood sugar levels.
• Monitor your blood sugar levels regularly as directed by your healthcare provider.
• Stay hydrated and drink plenty of fluids while taking this medication.
• attend regular check-ups with your healthcare provider to monitor your response to treatment and adjust the dosage if necessary.
• Carry a form of identification or wear a medical alert bracelet to inform others that you are taking Cyblex D in case of emergencies.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• About dapagliflozin (NHS UK) [Accessed 1 Jun. 2024] (online) Available at:
• Forxiga 10 mg film-coated tablets (Health Professionals SmPC) Available at:
• Dapagliflozin (Drugs.com) [Accessed 24 Jun. 2024] (online) Available at:
• dapagliflozin propaned 10 mg-metformin er 1,000 mg tablet,ext rel 24hr antihyperglycemic-sod/gluc cotransport-2 (sglt2) inhibitors (RX) [Accessed 23 Jun. 2024] (online) Available at:
• Dapagliflozin (MedlinePlus) [Accessed 25 Jun. 2024] (online) Available at:
• Dhillon S. Dapagliflozin: A Review in Type 2 Diabetes. Drugs. 2019 Jul;79(10):1135-1146. doi: 10.1007/s40265-019-01148-3. [Accessed 15 Jun. 2024] Available at: